APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lacosamide Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lacosamide Drugs Market Analysis and Forecast 2026-2032

Report ID 174006230227 December 2025206 pages

Choose your research edition.

Industry ResearchLacosamide Drugs Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Lacosamide Drugs Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Lacosamide Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lacosamide Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Lacosamide Drugs Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Lacosamide Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lacosamide Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lacosamide Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lacosamide Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lacosamide Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Lacosamide Drugs include Zhejiang Huahai Pharmaceutical, CSPC Ouyi Pharmaceutical, Shijiazhuang No.4 Pharmaceutical, Shandong Loncom Pharmaceutical, Jiangxi Qingfeng Pharmaceutical, Jiangsu Haian Pharmaceutical, Jianmin Group, Hefei Yifan Biopharmaceuticals and Buchang Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lacosamide Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lacosamide Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Lacosamide Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lacosamide Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lacosamide Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lacosamide Drugs sales, projected growth trends, production technology, application and end-user industry.

Lacosamide Drugs Segment by Company

Zhejiang Huahai Pharmaceutical

CSPC Ouyi Pharmaceutical

Shijiazhuang No.4 Pharmaceutical

Shandong Loncom Pharmaceutical

Jiangxi Qingfeng Pharmaceutical

Jiangsu Haian Pharmaceutical

Jianmin Group

Hefei Yifan Biopharmaceuticals

Buchang Pharmaceutical

Beijing Sihuan Pharmaceutical

UCB Pharma

Teva

Sun Pharma

Sandoz

Mylan

Glenmark Pharmaceuticals

Camber Pharma

Aucta Pharma

Apotex

Actavis

Lacosamide Drugs Segment by Type

Oral Solution

Tablets

Injection

Lacosamide Drugs Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Lacosamide Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lacosamide Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lacosamide Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lacosamide Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Lacosamide Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Lacosamide Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lacosamide Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lacosamide Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Solution Major Manufacturers Table 3. Tablets Major Manufacturers Table 4. Injection Major Manufacturers Table 5. Global Lacosamide Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital and Clinic Major Manufacturers Table 7. Retail Pharmacies Major Manufacturers Table 8. Other Major Manufacturers Table 9. Lacosamide Drugs Industry Trends Table 10. Lacosamide Drugs Industry Drivers Table 11. Lacosamide Drugs Industry Opportunities and Challenges Table 12. Lacosamide Drugs Industry Restraints Table 13. Global Lacosamide Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Lacosamide Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Lacosamide Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Lacosamide Drugs Revenue Market Share by Region (2021-2026) Table 17. Global Lacosamide Drugs Revenue Market Share by Region (2027-2032) Table 18. Global Lacosamide Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Lacosamide Drugs Sales by Region (2021-2026) & (K Units) Table 20. Global Lacosamide Drugs Sales by Region (2027-2032) & (K Units) Table 21. Global Lacosamide Drugs Sales Market Share by Region (2021-2026) Table 22. Global Lacosamide Drugs Sales Market Share by Region (2027-2032) Table 23. Global Lacosamide Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Lacosamide Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Lacosamide Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Lacosamide Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global Lacosamide Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Lacosamide Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Lacosamide Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Lacosamide Drugs Manufacturers, Product Type & Application Table 31. Global Lacosamide Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Lacosamide Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Lacosamide Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Lacosamide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Lacosamide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Lacosamide Drugs Revenue Market Share by Type (2021-2026) Table 38. Global Lacosamide Drugs Revenue Market Share by Type (2027-2032) Table 39. Global Lacosamide Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Lacosamide Drugs Sales by Type (2021-2026) & (K Units) Table 41. Global Lacosamide Drugs Sales by Type (2027-2032) & (K Units) Table 42. Global Lacosamide Drugs Sales Market Share by Type (2021-2026) Table 43. Global Lacosamide Drugs Sales Market Share by Type (2027-2032) Table 44. Global Lacosamide Drugs Price by Type (2021-2026) & (US$/Unit) Table 45. Global Lacosamide Drugs Price by Type (2027-2032) & (US$/Unit) Table 46. Global Lacosamide Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Lacosamide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Lacosamide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Lacosamide Drugs Revenue Market Share by Application (2021-2026) Table 50. Global Lacosamide Drugs Revenue Market Share by Application (2027-2032) Table 51. Global Lacosamide Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Lacosamide Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Lacosamide Drugs Sales by Application (2027-2032) & (K Units) Table 54. Global Lacosamide Drugs Sales Market Share by Application (2021-2026) Table 55. Global Lacosamide Drugs Sales Market Share by Application (2027-2032) Table 56. Global Lacosamide Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Lacosamide Drugs Price by Application (2027-2032) & (US$/Unit) Table 58. Zhejiang Huahai Pharmaceutical Company Information Table 59. Zhejiang Huahai Pharmaceutical Business Overview Table 60. Zhejiang Huahai Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Zhejiang Huahai Pharmaceutical Lacosamide Drugs Product Portfolio Table 62. Zhejiang Huahai Pharmaceutical Recent Development Table 63. CSPC Ouyi Pharmaceutical Company Information Table 64. CSPC Ouyi Pharmaceutical Business Overview Table 65. CSPC Ouyi Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. CSPC Ouyi Pharmaceutical Lacosamide Drugs Product Portfolio Table 67. CSPC Ouyi Pharmaceutical Recent Development Table 68. Shijiazhuang No.4 Pharmaceutical Company Information Table 69. Shijiazhuang No.4 Pharmaceutical Business Overview Table 70. Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Product Portfolio Table 72. Shijiazhuang No.4 Pharmaceutical Recent Development Table 73. Shandong Loncom Pharmaceutical Company Information Table 74. Shandong Loncom Pharmaceutical Business Overview Table 75. Shandong Loncom Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Shandong Loncom Pharmaceutical Lacosamide Drugs Product Portfolio Table 77. Shandong Loncom Pharmaceutical Recent Development Table 78. Jiangxi Qingfeng Pharmaceutical Company Information Table 79. Jiangxi Qingfeng Pharmaceutical Business Overview Table 80. Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Product Portfolio Table 82. Jiangxi Qingfeng Pharmaceutical Recent Development Table 83. Jiangsu Haian Pharmaceutical Company Information Table 84. Jiangsu Haian Pharmaceutical Business Overview Table 85. Jiangsu Haian Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Jiangsu Haian Pharmaceutical Lacosamide Drugs Product Portfolio Table 87. Jiangsu Haian Pharmaceutical Recent Development Table 88. Jianmin Group Company Information Table 89. Jianmin Group Business Overview Table 90. Jianmin Group Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Jianmin Group Lacosamide Drugs Product Portfolio Table 92. Jianmin Group Recent Development Table 93. Hefei Yifan Biopharmaceuticals Company Information Table 94. Hefei Yifan Biopharmaceuticals Business Overview Table 95. Hefei Yifan Biopharmaceuticals Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Hefei Yifan Biopharmaceuticals Lacosamide Drugs Product Portfolio Table 97. Hefei Yifan Biopharmaceuticals Recent Development Table 98. Buchang Pharmaceutical Company Information Table 99. Buchang Pharmaceutical Business Overview Table 100. Buchang Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Buchang Pharmaceutical Lacosamide Drugs Product Portfolio Table 102. Buchang Pharmaceutical Recent Development Table 103. Beijing Sihuan Pharmaceutical Company Information Table 104. Beijing Sihuan Pharmaceutical Business Overview Table 105. Beijing Sihuan Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Beijing Sihuan Pharmaceutical Lacosamide Drugs Product Portfolio Table 107. Beijing Sihuan Pharmaceutical Recent Development Table 108. UCB Pharma Company Information Table 109. UCB Pharma Business Overview Table 110. UCB Pharma Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. UCB Pharma Lacosamide Drugs Product Portfolio Table 112. UCB Pharma Recent Development Table 113. Teva Company Information Table 114. Teva Business Overview Table 115. Teva Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Teva Lacosamide Drugs Product Portfolio Table 117. Teva Recent Development Table 118. Sun Pharma Company Information Table 119. Sun Pharma Business Overview Table 120. Sun Pharma Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Sun Pharma Lacosamide Drugs Product Portfolio Table 122. Sun Pharma Recent Development Table 123. Sandoz Company Information Table 124. Sandoz Business Overview Table 125. Sandoz Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Sandoz Lacosamide Drugs Product Portfolio Table 127. Sandoz Recent Development Table 128. Mylan Company Information Table 129. Mylan Business Overview Table 130. Mylan Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Mylan Lacosamide Drugs Product Portfolio Table 132. Mylan Recent Development Table 133. Glenmark Pharmaceuticals Company Information Table 134. Glenmark Pharmaceuticals Business Overview Table 135. Glenmark Pharmaceuticals Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Glenmark Pharmaceuticals Lacosamide Drugs Product Portfolio Table 137. Glenmark Pharmaceuticals Recent Development Table 138. Camber Pharma Company Information Table 139. Camber Pharma Business Overview Table 140. Camber Pharma Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Camber Pharma Lacosamide Drugs Product Portfolio Table 142. Camber Pharma Recent Development Table 143. Aucta Pharma Company Information Table 144. Aucta Pharma Business Overview Table 145. Aucta Pharma Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Aucta Pharma Lacosamide Drugs Product Portfolio Table 147. Aucta Pharma Recent Development Table 148. Apotex Company Information Table 149. Apotex Business Overview Table 150. Apotex Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Apotex Lacosamide Drugs Product Portfolio Table 152. Apotex Recent Development Table 153. Actavis Company Information Table 154. Actavis Business Overview Table 155. Actavis Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Actavis Lacosamide Drugs Product Portfolio Table 157. Actavis Recent Development Table 158. North America Lacosamide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 159. North America Lacosamide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 160. North America Lacosamide Drugs Sales by Type (2021-2026) & (K Units) Table 161. North America Lacosamide Drugs Sales by Type (2027-2032) & (K Units) Table 162. North America Lacosamide Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 163. North America Lacosamide Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 164. North America Lacosamide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 165. North America Lacosamide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 166. North America Lacosamide Drugs Sales by Application (2021-2026) & (K Units) Table 167. North America Lacosamide Drugs Sales by Application (2027-2032) & (K Units) Table 168. North America Lacosamide Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 169. North America Lacosamide Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 170. North America Lacosamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. North America Lacosamide Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. North America Lacosamide Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. North America Lacosamide Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. North America Lacosamide Drugs Sales by Country (2021-2026) & (K Units) Table 175. North America Lacosamide Drugs Sales by Country (2027-2032) & (K Units) Table 176. North America Lacosamide Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 177. North America Lacosamide Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 178. United States Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 179. Canada Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 180. Mexico Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 181. Europe Lacosamide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 182. Europe Lacosamide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 183. Europe Lacosamide Drugs Sales by Type (2021-2026) & (K Units) Table 184. Europe Lacosamide Drugs Sales by Type (2027-2032) & (K Units) Table 185. Europe Lacosamide Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 186. Europe Lacosamide Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 187. Europe Lacosamide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 188. Europe Lacosamide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 189. Europe Lacosamide Drugs Sales by Application (2021-2026) & (K Units) Table 190. Europe Lacosamide Drugs Sales by Application (2027-2032) & (K Units) Table 191. Europe Lacosamide Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 192. Europe Lacosamide Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 193. Europe Lacosamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Europe Lacosamide Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Europe Lacosamide Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Europe Lacosamide Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 197. Europe Lacosamide Drugs Sales by Country (2021-2026) & (K Units) Table 198. Europe Lacosamide Drugs Sales by Country (2027-2032) & (K Units) Table 199. Europe Lacosamide Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 200. Europe Lacosamide Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 201. Germany Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 202. France Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 203. U.K. Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 204. Italy Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 205. Russia Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 206. Spain Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 207. Netherlands Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 208. Switzerland Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 209. Sweden Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 210. Poland Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 211. China Lacosamide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 212. China Lacosamide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 213. China Lacosamide Drugs Sales by Type (2021-2026) & (K Units) Table 214. China Lacosamide Drugs Sales by Type (2027-2032) & (K Units) Table 215. China Lacosamide Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 216. China Lacosamide Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 217. China Lacosamide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 218. China Lacosamide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 219. China Lacosamide Drugs Sales by Application (2021-2026) & (K Units) Table 220. China Lacosamide Drugs Sales by Application (2027-2032) & (K Units) Table 221. China Lacosamide Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 222. China Lacosamide Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 223. Asia Lacosamide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 224. Asia Lacosamide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 225. Asia Lacosamide Drugs Sales by Type (2021-2026) & (K Units) Table 226. Asia Lacosamide Drugs Sales by Type (2027-2032) & (K Units) Table 227. Asia Lacosamide Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 228. Asia Lacosamide Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 229. Asia Lacosamide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 230. Asia Lacosamide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 231. Asia Lacosamide Drugs Sales by Application (2021-2026) & (K Units) Table 232. Asia Lacosamide Drugs Sales by Application (2027-2032) & (K Units) Table 233. Asia Lacosamide Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 234. Asia Lacosamide Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 235. Asia Lacosamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 236. Asia Lacosamide Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 237. Asia Lacosamide Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 238. Asia Lacosamide Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 239. Asia Lacosamide Drugs Sales by Country (2021-2026) & (K Units) Table 240. Asia Lacosamide Drugs Sales by Country (2027-2032) & (K Units) Table 241. Asia Lacosamide Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 242. Asia Lacosamide Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 243. Japan Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 244. South Korea Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 245. India Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 246. Australia Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 247. Taiwan Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 248. Southeast Asia Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 249. SAMEA Lacosamide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 250. SAMEA Lacosamide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 251. SAMEA Lacosamide Drugs Sales by Type (2021-2026) & (K Units) Table 252. SAMEA Lacosamide Drugs Sales by Type (2027-2032) & (K Units) Table 253. SAMEA Lacosamide Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 254. SAMEA Lacosamide Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 255. SAMEA Lacosamide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 256. SAMEA Lacosamide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 257. SAMEA Lacosamide Drugs Sales by Application (2021-2026) & (K Units) Table 258. SAMEA Lacosamide Drugs Sales by Application (2027-2032) & (K Units) Table 259. SAMEA Lacosamide Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 260. SAMEA Lacosamide Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 261. SAMEA Lacosamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 262. SAMEA Lacosamide Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 263. SAMEA Lacosamide Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 264. SAMEA Lacosamide Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 265. SAMEA Lacosamide Drugs Sales by Country (2021-2026) & (K Units) Table 266. SAMEA Lacosamide Drugs Sales by Country (2027-2032) & (K Units) Table 267. SAMEA Lacosamide Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 268. SAMEA Lacosamide Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 269. Brazil Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 270. Argentina Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 271. Chile Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 272. Colombia Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 273. Peru Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 274. Saudi Arabia Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 275. Israel Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 276. UAE Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 277. Turkey Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 278. Iran Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 279. Egypt Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Table 280. Key Raw Materials Table 281. Raw Materials Key Suppliers Table 282. Lacosamide Drugs Distributors List Table 283. Lacosamide Drugs Customers List Table 284. Research Programs/Design for This Report Table 285. Authors List of This Report Table 286. Secondary Sources Table 287. Primary Sources List of Figures Figure 1. Lacosamide Drugs Image Figure 2. Global Lacosamide Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lacosamide Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Solution Image Figure 5. Tablets Image Figure 6. Injection Image Figure 7. Global Lacosamide Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Lacosamide Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital and Clinic Image Figure 10. Retail Pharmacies Image Figure 11. Other Image Figure 12. Global Lacosamide Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global Lacosamide Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Lacosamide Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Lacosamide Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global Lacosamide Drugs Sales (2021-2032) & (K Units) Figure 18. Global Lacosamide Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Lacosamide Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Lacosamide Drugs Sales YoY (2021-2032) & (K Units) Figure 21. Europe Lacosamide Drugs Sales YoY (2021-2032) & (K Units) Figure 22. China Lacosamide Drugs Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Lacosamide Drugs Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Lacosamide Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Global Lacosamide Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Lacosamide Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Lacosamide Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Lacosamide Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Lacosamide Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global Lacosamide Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Lacosamide Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Lacosamide Drugs Sales Market Share by Type (2021-2032) Figure 34. Global Lacosamide Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Lacosamide Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Lacosamide Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global Lacosamide Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Lacosamide Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Lacosamide Drugs Sales Market Share by Application (2021-2032) Figure 40. North America Lacosamide Drugs Revenue Share by Type (2021-2032) Figure 41. North America Lacosamide Drugs Sales Share by Type (2021-2032) Figure 42. North America Lacosamide Drugs Revenue Share by Application (2021-2032) Figure 43. North America Lacosamide Drugs Sales Share by Application (2021-2032) Figure 44. North America Lacosamide Drugs Revenue Share by Country (2021-2032) Figure 45. North America Lacosamide Drugs Sales Share by Country (2021-2032) Figure 46. Europe Lacosamide Drugs Revenue Share by Type (2021-2032) Figure 47. Europe Lacosamide Drugs Sales Share by Type (2021-2032) Figure 48. Europe Lacosamide Drugs Revenue Share by Application (2021-2032) Figure 49. Europe Lacosamide Drugs Sales Share by Application (2021-2032) Figure 50. Europe Lacosamide Drugs Revenue Share by Country (2021-2032) Figure 51. Europe Lacosamide Drugs Sales Share by Country (2021-2032) Figure 52. China Lacosamide Drugs Revenue Share by Type (2021-2032) Figure 53. China Lacosamide Drugs Sales Share by Type (2021-2032) Figure 54. China Lacosamide Drugs Revenue Share by Application (2021-2032) Figure 55. China Lacosamide Drugs Sales Share by Application (2021-2032) Figure 56. Asia Lacosamide Drugs Revenue Share by Type (2021-2032) Figure 57. Asia Lacosamide Drugs Sales Share by Type (2021-2032) Figure 58. Asia Lacosamide Drugs Revenue Share by Application (2021-2032) Figure 59. Asia Lacosamide Drugs Sales Share by Application (2021-2032) Figure 60. Asia Lacosamide Drugs Revenue Share by Country (2021-2032) Figure 61. Asia Lacosamide Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA Lacosamide Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA Lacosamide Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA Lacosamide Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Lacosamide Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA Lacosamide Drugs Revenue Share by Country (2021-2032) Figure 67. SAMEA Lacosamide Drugs Sales Share by Country (2021-2032) Figure 68. Lacosamide Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Lacosamide Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Solution
  • Tablets
  • Injection
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • CSPC Ouyi Pharmaceutical
  • Shijiazhuang No.4 Pharmaceutical
  • Shandong Loncom Pharmaceutical
  • Jiangxi Qingfeng Pharmaceutical
  • Jiangsu Haian Pharmaceutical
  • Jianmin Group
  • Hefei Yifan Biopharmaceuticals
  • Buchang Pharmaceutical
  • Beijing Sihuan Pharmaceutical
  • UCB Pharma
  • Teva
  • Sun Pharma
  • Sandoz
  • Mylan
  • Glenmark Pharmaceuticals
  • Camber Pharma
  • Aucta Pharma
  • Apotex
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lacosamide Drugs Market by Type
  3. 1.2.1 Global Lacosamide Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Solution
  5. 1.2.3 Tablets
  6. 1.2.4 Injection
  7. 1.3 Lacosamide Drugs Market by Application
  8. 1.3.1 Global Lacosamide Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital and Clinic
  10. 1.3.3 Retail Pharmacies
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Lacosamide Drugs Market Dynamics
  1. 2.1 Lacosamide Drugs Industry Trends
  2. 2.2 Lacosamide Drugs Industry Drivers
  3. 2.3 Lacosamide Drugs Industry Opportunities and Challenges
  4. 2.4 Lacosamide Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Lacosamide Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Lacosamide Drugs Revenue by Region
  3. 3.2.1 Global Lacosamide Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lacosamide Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Lacosamide Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Lacosamide Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Lacosamide Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Lacosamide Drugs Sales by Region
  9. 3.4.1 Global Lacosamide Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Lacosamide Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Lacosamide Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Lacosamide Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Lacosamide Drugs Revenue by Manufacturers
  2. 4.1.1 Global Lacosamide Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Lacosamide Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Lacosamide Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lacosamide Drugs Sales by Manufacturers
  6. 4.2.1 Global Lacosamide Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Lacosamide Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Lacosamide Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Lacosamide Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Lacosamide Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Lacosamide Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Lacosamide Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Lacosamide Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Lacosamide Drugs Market CR5 and HHI
  16. 4.8.2 2025 Lacosamide Drugs Tier 1, Tier 2, and Tier 3
5 Lacosamide Drugs Market by Type
  1. 5.1 Global Lacosamide Drugs Revenue by Type
  2. 5.1.1 Global Lacosamide Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Lacosamide Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Lacosamide Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Lacosamide Drugs Sales by Type
  6. 5.2.1 Global Lacosamide Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lacosamide Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Lacosamide Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Lacosamide Drugs Price by Type
6 Lacosamide Drugs Market by Application
  1. 6.1 Global Lacosamide Drugs Revenue by Application
  2. 6.1.1 Global Lacosamide Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Lacosamide Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Lacosamide Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Lacosamide Drugs Sales by Application
  6. 6.2.1 Global Lacosamide Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Lacosamide Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Lacosamide Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Lacosamide Drugs Price by Application
7 Company Profiles
  1. 7.1 Zhejiang Huahai Pharmaceutical
  2. 7.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 7.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 7.1.3 Zhejiang Huahai Pharmaceutical Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zhejiang Huahai Pharmaceutical Lacosamide Drugs Product Portfolio
  6. 7.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 7.2 CSPC Ouyi Pharmaceutical
  8. 7.2.1 CSPC Ouyi Pharmaceutical Company Information
  9. 7.2.2 CSPC Ouyi Pharmaceutical Business Overview
  10. 7.2.3 CSPC Ouyi Pharmaceutical Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CSPC Ouyi Pharmaceutical Lacosamide Drugs Product Portfolio
  12. 7.2.5 CSPC Ouyi Pharmaceutical Recent Developments
  13. 7.3 Shijiazhuang No.4 Pharmaceutical
  14. 7.3.1 Shijiazhuang No.4 Pharmaceutical Company Information
  15. 7.3.2 Shijiazhuang No.4 Pharmaceutical Business Overview
  16. 7.3.3 Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Product Portfolio
  18. 7.3.5 Shijiazhuang No.4 Pharmaceutical Recent Developments
  19. 7.4 Shandong Loncom Pharmaceutical
  20. 7.4.1 Shandong Loncom Pharmaceutical Company Information
  21. 7.4.2 Shandong Loncom Pharmaceutical Business Overview
  22. 7.4.3 Shandong Loncom Pharmaceutical Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Shandong Loncom Pharmaceutical Lacosamide Drugs Product Portfolio
  24. 7.4.5 Shandong Loncom Pharmaceutical Recent Developments
  25. 7.5 Jiangxi Qingfeng Pharmaceutical
  26. 7.5.1 Jiangxi Qingfeng Pharmaceutical Company Information
  27. 7.5.2 Jiangxi Qingfeng Pharmaceutical Business Overview
  28. 7.5.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Product Portfolio
  30. 7.5.5 Jiangxi Qingfeng Pharmaceutical Recent Developments
  31. 7.6 Jiangsu Haian Pharmaceutical
  32. 7.6.1 Jiangsu Haian Pharmaceutical Company Information
  33. 7.6.2 Jiangsu Haian Pharmaceutical Business Overview
  34. 7.6.3 Jiangsu Haian Pharmaceutical Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Jiangsu Haian Pharmaceutical Lacosamide Drugs Product Portfolio
  36. 7.6.5 Jiangsu Haian Pharmaceutical Recent Developments
  37. 7.7 Jianmin Group
  38. 7.7.1 Jianmin Group Company Information
  39. 7.7.2 Jianmin Group Business Overview
  40. 7.7.3 Jianmin Group Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Jianmin Group Lacosamide Drugs Product Portfolio
  42. 7.7.5 Jianmin Group Recent Developments
  43. 7.8 Hefei Yifan Biopharmaceuticals
  44. 7.8.1 Hefei Yifan Biopharmaceuticals Company Information
  45. 7.8.2 Hefei Yifan Biopharmaceuticals Business Overview
  46. 7.8.3 Hefei Yifan Biopharmaceuticals Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hefei Yifan Biopharmaceuticals Lacosamide Drugs Product Portfolio
  48. 7.8.5 Hefei Yifan Biopharmaceuticals Recent Developments
  49. 7.9 Buchang Pharmaceutical
  50. 7.9.1 Buchang Pharmaceutical Company Information
  51. 7.9.2 Buchang Pharmaceutical Business Overview
  52. 7.9.3 Buchang Pharmaceutical Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Buchang Pharmaceutical Lacosamide Drugs Product Portfolio
  54. 7.9.5 Buchang Pharmaceutical Recent Developments
  55. 7.10 Beijing Sihuan Pharmaceutical
  56. 7.10.1 Beijing Sihuan Pharmaceutical Company Information
  57. 7.10.2 Beijing Sihuan Pharmaceutical Business Overview
  58. 7.10.3 Beijing Sihuan Pharmaceutical Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Beijing Sihuan Pharmaceutical Lacosamide Drugs Product Portfolio
  60. 7.10.5 Beijing Sihuan Pharmaceutical Recent Developments
  61. 7.11 UCB Pharma
  62. 7.11.1 UCB Pharma Company Information
  63. 7.11.2 UCB Pharma Business Overview
  64. 7.11.3 UCB Pharma Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 UCB Pharma Lacosamide Drugs Product Portfolio
  66. 7.11.5 UCB Pharma Recent Developments
  67. 7.12 Teva
  68. 7.12.1 Teva Company Information
  69. 7.12.2 Teva Business Overview
  70. 7.12.3 Teva Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Teva Lacosamide Drugs Product Portfolio
  72. 7.12.5 Teva Recent Developments
  73. 7.13 Sun Pharma
  74. 7.13.1 Sun Pharma Company Information
  75. 7.13.2 Sun Pharma Business Overview
  76. 7.13.3 Sun Pharma Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Sun Pharma Lacosamide Drugs Product Portfolio
  78. 7.13.5 Sun Pharma Recent Developments
  79. 7.14 Sandoz
  80. 7.14.1 Sandoz Company Information
  81. 7.14.2 Sandoz Business Overview
  82. 7.14.3 Sandoz Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Sandoz Lacosamide Drugs Product Portfolio
  84. 7.14.5 Sandoz Recent Developments
  85. 7.15 Mylan
  86. 7.15.1 Mylan Company Information
  87. 7.15.2 Mylan Business Overview
  88. 7.15.3 Mylan Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Mylan Lacosamide Drugs Product Portfolio
  90. 7.15.5 Mylan Recent Developments
  91. 7.16 Glenmark Pharmaceuticals
  92. 7.16.1 Glenmark Pharmaceuticals Company Information
  93. 7.16.2 Glenmark Pharmaceuticals Business Overview
  94. 7.16.3 Glenmark Pharmaceuticals Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Glenmark Pharmaceuticals Lacosamide Drugs Product Portfolio
  96. 7.16.5 Glenmark Pharmaceuticals Recent Developments
  97. 7.17 Camber Pharma
  98. 7.17.1 Camber Pharma Company Information
  99. 7.17.2 Camber Pharma Business Overview
  100. 7.17.3 Camber Pharma Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Camber Pharma Lacosamide Drugs Product Portfolio
  102. 7.17.5 Camber Pharma Recent Developments
  103. 7.18 Aucta Pharma
  104. 7.18.1 Aucta Pharma Company Information
  105. 7.18.2 Aucta Pharma Business Overview
  106. 7.18.3 Aucta Pharma Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Aucta Pharma Lacosamide Drugs Product Portfolio
  108. 7.18.5 Aucta Pharma Recent Developments
  109. 7.19 Apotex
  110. 7.19.1 Apotex Company Information
  111. 7.19.2 Apotex Business Overview
  112. 7.19.3 Apotex Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Apotex Lacosamide Drugs Product Portfolio
  114. 7.19.5 Apotex Recent Developments
  115. 7.20 Actavis
  116. 7.20.1 Actavis Company Information
  117. 7.20.2 Actavis Business Overview
  118. 7.20.3 Actavis Lacosamide Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Actavis Lacosamide Drugs Product Portfolio
  120. 7.20.5 Actavis Recent Developments
8 North America
  1. 8.1 North America Lacosamide Drugs Market Size by Type
  2. 8.1.1 North America Lacosamide Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Lacosamide Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Lacosamide Drugs Price by Type (2021-2032)
  5. 8.2 North America Lacosamide Drugs Market Size by Application
  6. 8.2.1 North America Lacosamide Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Lacosamide Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Lacosamide Drugs Price by Application (2021-2032)
  9. 8.3 North America Lacosamide Drugs Market Size by Country
  10. 8.3.1 North America Lacosamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Lacosamide Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Lacosamide Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Lacosamide Drugs Market Size by Type
  2. 9.1.1 Europe Lacosamide Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Lacosamide Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Lacosamide Drugs Price by Type (2021-2032)
  5. 9.2 Europe Lacosamide Drugs Market Size by Application
  6. 9.2.1 Europe Lacosamide Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Lacosamide Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Lacosamide Drugs Price by Application (2021-2032)
  9. 9.3 Europe Lacosamide Drugs Market Size by Country
  10. 9.3.1 Europe Lacosamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Lacosamide Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Lacosamide Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Lacosamide Drugs Market Size by Type
  2. 10.1.1 China Lacosamide Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Lacosamide Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Lacosamide Drugs Price by Type (2021-2032)
  5. 10.2 China Lacosamide Drugs Market Size by Application
  6. 10.2.1 China Lacosamide Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Lacosamide Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Lacosamide Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lacosamide Drugs Market Size by Type
  2. 11.1.1 Asia Lacosamide Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Lacosamide Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Lacosamide Drugs Price by Type (2021-2032)
  5. 11.2 Asia Lacosamide Drugs Market Size by Application
  6. 11.2.1 Asia Lacosamide Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Lacosamide Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Lacosamide Drugs Price by Application (2021-2032)
  9. 11.3 Asia Lacosamide Drugs Market Size by Country
  10. 11.3.1 Asia Lacosamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Lacosamide Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Lacosamide Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lacosamide Drugs Market Size by Type
  2. 12.1.1 SAMEA Lacosamide Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Lacosamide Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Lacosamide Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Lacosamide Drugs Market Size by Application
  6. 12.2.1 SAMEA Lacosamide Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Lacosamide Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Lacosamide Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Lacosamide Drugs Market Size by Country
  10. 12.3.1 SAMEA Lacosamide Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Lacosamide Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Lacosamide Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Lacosamide Drugs Value Chain Analysis
  2. 13.1.1 Lacosamide Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Lacosamide Drugs Production Mode & Process
  6. 13.2 Lacosamide Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Lacosamide Drugs Distributors
  9. 13.2.3 Lacosamide Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst